| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.09. | Xebra Brands Ltd (2): Xebra's 1:10 rollback to be delayed until CTO revoked | 3 | Stockwatch | ||
| XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
| 19.09. | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 235 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025,... ► Artikel lesen | |
| 13.09. | Xebra Brands Ltd (2): Xebra Brands to roll back shares one for 10 Sept. 19 | 3 | Stockwatch | ||
| 13.09. | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 476 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025)... ► Artikel lesen | |
| 04.09. | CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA) | 336 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt... ► Artikel lesen | |
| 04.09. | Xebra Brands Ltd (2): Xebra Brands suspended by CSE | 3 | Stockwatch | ||
| 04.09. | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 256 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 22.08. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 1 | Stockwatch | ||
| 22.08. | Xebra Brands Ltd: Xebra Brands Announces Issuance of Cease Trade Order | 442 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 22, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (XBRA:CSE)(XBRAF:OTC PINK)(9YC:FSE), a cannabis company, announces that the Company does not expect to... ► Artikel lesen | |
| 16.08. | Xebra Brands Ltd: Xebra Brands Announces Share Consolidation and Provides Update on MCTO | 575 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 15, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), a international cannabis company, announces that it intends to consolidate its issued and outstanding... ► Artikel lesen | |
| 02.08. | Xebra Brands Ltd (2): Xebra Brands has no material changes | 2 | Stockwatch | ||
| 02.08. | Xebra Brands Ltd: Xebra Provides Update on MCTO | 748 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 1, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTC PINK:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 16.07. | Xebra Brands Ltd (2): Xebra hopes to file fiscal 2025 financials by Aug. 29 | 3 | Stockwatch | ||
| 16.07. | Xebra Brands Ltd: Xebra Provides Update on Management Cease Trade Order | 276 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 03.07. | Xebra Brands Ltd (2): Xebra Brands cancels LOI to acquire BSK | 5 | Stockwatch | ||
| 03.07. | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 452 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
| 24.06. | Xebra Brands Ltd (2): Xebra Brands clarifies not-yet-granted MCTO | 7 | Stockwatch | ||
| 23.06. | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 435 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
| 23.06. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 2 | Stockwatch | ||
| 23.06. | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 314 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 33,395 | -0,68 % | Pharmariese im Rallyemodus: Bayer-Aktie im boerse.de-Check | Die Bayer-Aktie sorgte vergangene Woche endlich wieder für positive Schlagzeilen. Nach einem langen Tief und mehreren vergeblichen Anläufen hat das Papier die psychologisch wichtige Marke von 30 Euro... ► Artikel lesen | |
| AURORA CANNABIS | 3,940 | +0,13 % | Aurora Cannabis Inc (3): Aurora Cannabis's MedReleaf adds Leafio as wholesaler | ||
| CANOPY GROWTH | 0,981 | -0,71 % | Canopy USA: Wana Brands Launches THC Gummies in Switzerland Through Pioneering Pilot Program | Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), announced today that the brand is launching its premium gummies in Zürich, Switzerland as... ► Artikel lesen | |
| TILRAY BRANDS | 6,285 | -0,24 % | XETR ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS88688T1007 Tilray Brands Inc. 01.12.2025 US88688T2096 Tilray Brands Inc. 02.12.2025 Tausch 10:1 ► Artikel lesen | |
| INNOCAN PHARMA | 6,100 | -3,17 % | Innocan Pharma gibt Finanzergebnisse für 3. Quartal 2025 bekannt - mit Umsätzen von 21,6 Mio. USD | Herzliya, Israel und Calgary, Alberta - 27. November 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTC: INNPF) (das
"Unternehmen" oder "Innocan"), ein pharmazeutisches... ► Artikel lesen | |
| CRONOS GROUP | 2,120 | -1,12 % | Cronos Group Inc.: Cronos Group Reports 2025 Second Quarter Results | Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong... ► Artikel lesen | |
| SYNBIOTIC | 1,684 | +1,20 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC verstärkt Präsenz auf internationalen Events und verfolgt Fortschritte in der Cannabisforschung | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Strategische Unternehmensentscheidung
SYNBIOTIC verstärkt Präsenz auf internationalen Events und verfolgt Fortschritte in der Cannabisforschung... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 48,600 | -0,82 % | Nektar Therapeutics: "Unser Wirkmechanismus ist breit gefächert"- CBO im Exklusiv-Interview ... | Die Biotech-Gesellschaft Nektar Therapeutics will mit innovativen Wirkmechanismen neue Behandlungsmöglichkeiten für Autoimmun- und Entzündungserkrankungen entwickeln. Auf der BIO-Europe hat DER AKTIONÄR... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,320 | +0,04 % | Oramed Pharmaceuticals Inc.: Oramed Reports Fiscal Third Quarter 2025 Financial Results | Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Million
NEW YORK, Nov. 17, 2025 /PRNewswire/ --... ► Artikel lesen | |
| OPKO HEALTH | 1,144 | -0,95 % | OPKO Health, Inc.: OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results | MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights... ► Artikel lesen | |
| JAGUAR HEALTH | 1,080 | -1,82 % | Jaguar Health, Inc.: Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study | Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved CanaleviaA novel non-antibiotic approach to diarrhea treatment is important because there... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,530 | +2,00 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification | - Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,550 | +0,73 % | XORTX Therapeutics Inc.: XORTX Announces Closing of US$1.1 Million Registered Direct Offering | CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| TALPHERA | 1,066 | -1,66 % | Talphera, Inc.: Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update | Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.
Cash and investments at September 30, 2025 were $21.3 million; combined... ► Artikel lesen |